Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report.
Boongird S, Chuengsaman P, Phanprasert S, Kitpermkiat R, Assanatham M, Nongnuch A, Kiertiburanakul S, Malathum K, Phuphuakrat A, Setthaudom C, Bruminhent J. Boongird S, et al. Among authors: phuphuakrat a. Kidney Int. 2021 Nov;100(5):1136-1138. doi: 10.1016/j.kint.2021.08.007. Epub 2021 Aug 19. Kidney Int. 2021. PMID: 34419552 Free PMC article. No abstract available.
A randomized controlled trial of sitafloxacin vs. ertapenem as a switch therapy after treatment for acute pyelonephritis caused by extended-spectrum β-lactamase-producing Escherichia coli: A pilot study.
Malaisri C, Phuphuakrat A, Wibulpolprasert A, Santanirand P, Kiertiburanakul S. Malaisri C, et al. Among authors: phuphuakrat a. J Infect Chemother. 2017 Aug;23(8):556-562. doi: 10.1016/j.jiac.2017.05.005. Epub 2017 Jun 3. J Infect Chemother. 2017. PMID: 28587974 Clinical Trial.
Efficacy of Rilpivirine-Based Regimens as Switch Therapy From Nevirapine-Based Regimens in Human Immunodeficiency Virus-Infected Patients With Virological Suppression: A Randomized Controlled Trial.
Petchkum P, Sungkanuparph S, Kiertiburanakul S, Phuphuakrat A. Petchkum P, et al. Among authors: phuphuakrat a. Open Forum Infect Dis. 2019 Mar 25;6(4):ofz155. doi: 10.1093/ofid/ofz155. eCollection 2019 Apr. Open Forum Infect Dis. 2019. PMID: 31041351 Free PMC article.
62 results